Patent · US Active

Phospholipid analogs as diapeutic* agents and methods thereof

US8535641B2 · kind B2 · utility

12Cited by
16References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 2, 2005
Grant dateSep 17, 2013
Priority date—
Expiry dateAug 3, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F13/005
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and uses of phospholipid ether analogs as diagnostic and therapeutic agents for numerous cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.